SALT LAKE CITY, Oct. 02, 2017 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today the appointment of Kevin McMurray to the position of General Counsel.
“We’re thrilled to have Kevin join our management team,” said LifeVantage President and Chief Executive Officer, Darren Jensen. “He brings a track record of success, an astute legal mind and a team-first philosophy to his work. He has deep experience in our industry, and guided businesses through similar periods of growth and evolution such as we are undertaking. I can’t think of anyone better suited to help us navigate our continued expansion.”
A veteran of the health and wellness industry, Mr. McMurray brings over 25 years of legal expertise to LifeVantage where he will be responsible for leading the legal department and serving as counsel to the Board of Directors, Chairman of the Board, and Chief Executive Officer. Prior to joining LifeVantage, Mr. McMurray served as Assistant General Counsel at USANA Health Sciences since 2004. While at USANA, he helped implement its first distributor compliance program while playing an integral role in the company’s expansion into new international markets.
“Throughout his career, Kevin has demonstrated the well-rounded ability to understand and navigate a broad range of legal issues,” said LifeVantage Chief Sales Officer, Justin Rose. “His industry experience combined with an uncanny ability to create innovative solutions that create real value is something we look forward to.”
Mr. McMurray also served as Associate General Counsel for Unicity International and Assistant General Counsel for Shaklee Corporation. He received his J.D. from Creighton University and a Master of Laws Degree from the University of the Pacific.
“I’m very excited about this new opportunity,” said McMurray. “I’ve always been drawn to the health and wellness industry because I love the lifestyle it promotes. LifeVantage has proven that it’s an industry leader with its innovative approach to product research and development. I look forward to being an active member of the management team as we grow and expand into new international markets.”
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and anti-aging company dedicated to helping people transform themselves internally and externally at a cellular level. Their scientifically-validated product line includes Protandim® Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen, Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our future growth, distributor success and shareholder value. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Scott Van Winkle
Managing Director, ICR